Movement Alert|CF Industries Falls 5.01% in Pre-Market Trading, BNP Paribas Cuts Target Price to $120

Market Focus
Jun 15

On June 15, CF Industries fell 5.01% in pre-market trading, trading at approximately $103.70/share, with turnover of $556,100.

On the news front, BNP Paribas cut its target price on CF Industries from $140 to $120, maintaining a neutral rating. According to analyst consensus data, the stock carries an average hold rating with a mean target price of $129.54, meaning the current share price has fallen below the lower end of most institutional expectations.

Within the Fertilizers & Agricultural Chemicals sector where CF Industries belongs, the overall sector performance is mixed. Among individual stocks, Scotts Miracle-Gro up 1.70%, Mosaic up 1.37%, FMC Corp up 1.27%, Corteva down 0.13%, Nutrien down 1.29%. CF Industries leads sector declines.

CF Industries Holdings manufactures and sells hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities worldwide. Its principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. The company was founded in 1946 and is headquartered in Deerfield, Illinois.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10